Literature DB >> 7482493

The relative distribution of B35 alleles and their IEF isotypes in a HLA-B35-positive population.

G Ragupathi1, N Cereb, S Y Yang.   

Abstract

The HLA-B35 serotype represents a group of antigens detectable by IEF, cytotoxic T cells, and by sequencing analysis. Four isotypes and eight alleles have been thus far reported. We have determined the relative frequencies of these B35 subtypes in a group of 203 unrelated people. Dot blot hybridization of PCR amplified products was performed using 23 sequence-specific oligo probes designed based on the EMBL HLA class I sequence database. The amplification was achieved by a pair of group-specific primers, producing approximately 600 bp fragments. By hybridization pattern analysis, we found that four alleles represent over 95% of the B35+ population, with relative frequency of 48.2% for B*3501, 23.7% for B*3502, 15.2% for B*3503, and 8.0% for B*3508. We also identified 3 individuals with B*3504 and one with B*3505, and seven samples with new patterns. B*3501 and B*3503 exactly correlated with the most common isotype B35.3, B*3502 and B*3504 with B35.2, B*3508 may be the B35.1 IEF isotype. The B*3505 was identified from an individual with B35 IEF variant form. Our study shows that the B35 antigen has a wide distribution of alleles, and that many more B35-related alleles may yet to be uncovered.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7482493     DOI: 10.1111/j.1399-0039.1995.tb02472.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  4 in total

1.  Motif of HLA-B*3503 peptide ligands.

Authors:  A Steinle; K Falk; O Rötzschke; V Gnau; S Stevanović; G Jung; D J Schendel; H G Rammensee
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

2.  High-resolution characterization of the structural features and genetic variation of six feline leukocyte antigen class I loci via single molecule, real-time (SMRT) sequencing.

Authors:  Jennifer C Holmes; Elizabeth H Scholl; Allison N Dickey; Paul R Hess
Journal:  Immunogenetics       Date:  2021-06-27       Impact factor: 2.846

3.  Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.

Authors:  Tatiana Pochechueva; Francis Jacob; Andre Fedier; Viola Heinzelmann-Schwarz
Journal:  Metabolites       Date:  2012-11-14

4.  Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes.

Authors:  Trishna Manandhar; Heike Kunze-Schumacher; Trevor Huyton; Alexander A Celik; Rainer Blasczyk; Christina Bade-Doeding
Journal:  Immunogenetics       Date:  2016-01-12       Impact factor: 2.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.